case_images: PMC6243353_01
case_images: Pleomorphic lymphoid cells present in the aspirated effusion. Subsequent immunohistochemical staining confirmed this to be breast implant-associated anaplastic large cell lymphoma.
case_images: bjrcr.20150424.g001.jpg
case_images: PMC6243353_01_bjrcr.20150424.g001.jpg
case_images: fig1
case_images: Cytological examination revealed malignancy, showing a population of lymphoid cells (Figure 1) that were positive for CD45, CD30, CD3, CD2 and CD4, and negative for EMA, CD20, CD79a and ALK-1.
case_images: Pre-operative contrast-enhanced CT scan (a) axial and (b) coronal views demonstrating right mastectomy with implant and associated effusion in the implant cavity.
case_images: bjrcr.20150424.g002.jpg
case_images: PMC6243353_01_bjrcr.20150424.g002.jpg
case_images: fig2
case_images: A contrast-enhanced CT scan of the chest, abdomen and pelvis confirmed an effusion within the right breast implant cavity (Figure 2) and showed no other evidence of disease.
case_images: (a) Axial and (b) coronal views ofpost-operative 18F-fludeoxyglucose positron emission tomography-CT demonstrating low level metabolic activity at the operative site, likely owingtopost-operative inflammation.
case_images: bjrcr.20150424.g003.jpg
case_images: PMC6243353_01_bjrcr.20150424.g003.jpg
case_images: fig3
case_images: A post-operative FDG PET-CT scan showed only low level metabolic activity [maximum standardized uptake (SUV) value of 2.4] that was limited to the chest wall at the recent operative site, which was considered postsurgical (Figure 3).
case_images: (a) Axial and (b) coronal views of 18F-fludeoxyglucose positron emission tomography-CT performed 3 months postoperatively demonstrating reduction of previous 18F-fludeoxyglucose uptake.
case_images: bjrcr.20150424.g004.jpg
case_images: PMC6243353_01_bjrcr.20150424.g004.jpg
case_images: fig4
case_images: At 3 months, there was no evidence of recurrence on repeat FDG PET-CT scan (Figure 4).
case_images: (a) Axial and (b) coronal views of 18F-fludeoxyglucose PET-CT scan performed 12 months postoperatively showing complete resolution of previous 18F-fludeoxyglucose uptake with no evidence of 18F-fludeoxyglucose-avid disease.
case_images: bjrcr.20150424.g005.jpg
case_images: PMC6243353_01_bjrcr.20150424.g005.jpg
case_images: fig5
case_images: A 12-month FDG PET-CT scan (Figure 5) showed resolution of the previous FDG uptake, with no evidence of FDG-avid disease.